Wendy Grant-McAuley, William Morgenlander, Sarah E Hudelson, Manjusha Thakar, Estelle Piwowar-Manning, William Clarke, Autumn Breaud, Joel Blankson, Ethan Wilson, Helen Ayles, Peter Bock, Ayana Moore, Barry Kosloff, Kwame Shanaube, Sue-Ann Meehan, Anneen van Deventer, Sarah Fidler, Richard Hayes, Ingo Ruczinski, Kai Kammers, Oliver Laeyendecker, H Benjamin Larman, Susan H Eshleman
BACKGROUND: High HIV viral load (VL) is associated with increased transmission risk and faster disease progression. HIV controllers achieve viral suppression without antiretroviral (ARV) treatment. We evaluated viremic control in a community-randomized trial with >48,000 participants. METHODS: A massively multiplexed antibody profiling system, VirScan, was used to quantify pre- and post-infection antibody reactivity to HIV peptides in 664 samples from 429 participants (13 controllers, 135 viremic non-controllers, 64 other non-controllers, 217 uninfected persons)...
2023: Frontiers in Immunology